LV12735B - AZITROMICIN ETHANOLATE, THEIR METHOD AND ITS PHARMACEUTICAL COMPOSITIONS - Google Patents

AZITROMICIN ETHANOLATE, THEIR METHOD AND ITS PHARMACEUTICAL COMPOSITIONS Download PDF

Info

Publication number
LV12735B
LV12735B LVP-01-79A LV010079A LV12735B LV 12735 B LV12735 B LV 12735B LV 010079 A LV010079 A LV 010079A LV 12735 B LV12735 B LV 12735B
Authority
LV
Latvia
Prior art keywords
ethanolate
azithromycin
suspension
water
ethanol
Prior art date
Application number
LVP-01-79A
Other languages
English (en)
Latvian (lv)
Other versions
LV12735A (en
Inventor
Claude Singer
Judith Aronhime
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22332273&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV12735(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of LV12735A publication Critical patent/LV12735A/xx
Publication of LV12735B publication Critical patent/LV12735B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LVP-01-79A 1998-11-30 2001-06-22 AZITROMICIN ETHANOLATE, THEIR METHOD AND ITS PHARMACEUTICAL COMPOSITIONS LV12735B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11029898P 1998-11-30 1998-11-30
PCT/US1999/028368 WO2000032203A1 (en) 1998-11-30 1999-11-30 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

Publications (2)

Publication Number Publication Date
LV12735A LV12735A (en) 2001-10-20
LV12735B true LV12735B (en) 2002-03-20

Family

ID=22332273

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-01-79A LV12735B (en) 1998-11-30 2001-06-22 AZITROMICIN ETHANOLATE, THEIR METHOD AND ITS PHARMACEUTICAL COMPOSITIONS

Country Status (26)

Country Link
US (1) US6365574B2 (ko)
EP (2) EP1484062A1 (ko)
JP (1) JP2002531409A (ko)
KR (1) KR100603226B1 (ko)
CN (2) CN100339384C (ko)
AP (1) AP1709A (ko)
AT (1) ATE279200T1 (ko)
AU (1) AU768219B2 (ko)
BG (1) BG105547A (ko)
CA (1) CA2352562A1 (ko)
CZ (1) CZ20011886A3 (ko)
DE (1) DE69921192T2 (ko)
DK (1) DK1152765T3 (ko)
ES (1) ES2229804T3 (ko)
HK (1) HK1043725B (ko)
HU (1) HUP0104241A3 (ko)
IL (1) IL143376A0 (ko)
LV (1) LV12735B (ko)
NZ (1) NZ512496A (ko)
PL (1) PL197894B1 (ko)
PT (1) PT1152765E (ko)
RO (1) RO121408B1 (ko)
RU (1) RU2240124C2 (ko)
SI (1) SI20639A (ko)
WO (1) WO2000032203A1 (ko)
ZA (1) ZA200104312B (ko)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
PT1152765E (pt) * 1998-11-30 2004-12-31 Teva Pharma Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem
CZ303343B6 (cs) * 2000-11-27 2012-08-08 Sandoz Ag Zpusob prípravy azithromycinu ve forme monohydrátu
UA76967C2 (uk) * 2000-11-27 2006-10-16 Сандоз Аг Азитроміцин у формі моногідрату, фармацевтична композиція та спосіб його одержання
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
EA007618B1 (ru) * 2001-05-22 2006-12-29 Пфайзер Продактс Инк. Кристаллический полуторогидрат азитромицина, содержащая его фармацевтическая композиция и способ лечения на его основе
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
EP1671979B1 (en) * 2001-05-22 2008-08-13 Pfizer Products Inc. New Cristal Form of Azithromycin
DE60232005D1 (de) * 2001-10-18 2009-05-28 Teva Pharma Stabilisierte azithromycin-zusammensetzungen
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
EP1541134A3 (en) * 2001-10-18 2007-06-06 Teva Pharmaceutical Industries Limited Stabilized azithromycin compositions
NZ532707A (en) * 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
BR0215175A (pt) * 2001-12-21 2004-12-28 Pfizer Prod Inc Métodos para a granulação úmida de azitromicina
JP2005526020A (ja) * 2002-02-01 2005-09-02 ファイザー・プロダクツ・インク アジスロマイシンの乾式造粒配合物
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
RU2006119453A (ru) * 2003-12-04 2007-12-20 Пфайзер Продактс Инк. (Us) Получение посредством основанных на применении жидкостей способов лекарственные формы азитромицина с большим количеством частиц
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
CA2549225A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
BRPI0416534A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
EP1691787B1 (en) * 2003-12-04 2008-07-02 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
CA2591744A1 (en) * 2004-12-21 2006-06-29 Pfizer Products Inc. Stable non-dihydrate azithromycin oral suspensions
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
BRPI1009823A2 (pt) 2009-03-13 2019-09-24 Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7 "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
WO2010121187A2 (en) * 2009-04-17 2010-10-21 Micell Techologies, Inc. Stents having controlled elution
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN103983730B (zh) * 2014-06-11 2015-09-30 北京市药品检验所 阿奇霉素或其制剂中的杂质检查方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
UA27040C2 (uk) * 1987-07-09 2000-02-28 Пфайзер Інк. Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
CN1093370A (zh) 1993-12-10 1994-10-12 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
CN1161971A (zh) * 1997-01-03 1997-10-15 石家庄制药集团有限公司 一种阿齐霉素结晶及其制备方法
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
PT1152765E (pt) * 1998-11-30 2004-12-31 Teva Pharma Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
EA007618B1 (ru) * 2001-05-22 2006-12-29 Пфайзер Продактс Инк. Кристаллический полуторогидрат азитромицина, содержащая его фармацевтическая композиция и способ лечения на его основе

Also Published As

Publication number Publication date
BG105547A (en) 2001-12-31
CN1737008A (zh) 2006-02-22
AP1709A (en) 2007-02-27
SI20639A (sl) 2002-02-28
EP1152765A4 (en) 2002-07-17
AU768219B2 (en) 2003-12-04
DE69921192D1 (de) 2004-11-18
CA2352562A1 (en) 2000-06-08
CN1334735A (zh) 2002-02-06
IL143376A0 (en) 2002-04-21
CN100339384C (zh) 2007-09-26
RO121408B1 (ro) 2007-05-30
WO2000032203A1 (en) 2000-06-08
PL197894B1 (pl) 2008-05-30
HUP0104241A3 (en) 2003-12-29
JP2002531409A (ja) 2002-09-24
DK1152765T3 (da) 2005-01-31
CN1273142C (zh) 2006-09-06
PL347971A1 (en) 2002-05-06
CZ20011886A3 (cs) 2001-10-17
EP1152765B1 (en) 2004-10-13
LV12735A (en) 2001-10-20
ZA200104312B (en) 2001-11-28
US20020007049A1 (en) 2002-01-17
DE69921192T2 (de) 2006-02-16
ATE279200T1 (de) 2004-10-15
HK1043725B (zh) 2005-05-06
EP1152765A1 (en) 2001-11-14
US6365574B2 (en) 2002-04-02
AP2001002183A0 (en) 2001-06-30
HK1043725A1 (en) 2002-09-27
NZ512496A (en) 2003-02-28
KR100603226B1 (ko) 2006-08-28
AU3106500A (en) 2000-06-19
RU2240124C2 (ru) 2004-11-20
HUP0104241A2 (hu) 2002-03-28
ES2229804T3 (es) 2005-04-16
EP1484062A1 (en) 2004-12-08
KR20010099806A (ko) 2001-11-09
PT1152765E (pt) 2004-12-31

Similar Documents

Publication Publication Date Title
LV12735B (en) AZITROMICIN ETHANOLATE, THEIR METHOD AND ITS PHARMACEUTICAL COMPOSITIONS
US5635613A (en) Process for preparing crystal forms and solvates of dirithromycin
WO2000032203A9 (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
JP4584162B2 (ja) 結晶形アジスロマイシン
RU2066324C1 (ru) Кристаллический дигидрат азитромицина и способ его получения
EP1254146B1 (en) Processes for preparing clarithromycin polymorphs and novel polymorph iv
US6586576B2 (en) Preparation method of azithromycin hydrates
NZ529082A (en) Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same
EP2342212A1 (en) Thermally stable crystalline epirubicin hydrochloride
CA2067274C (en) Solvates of dirithromycin and a process for isolating form ii dirithromycin
CA2376748C (en) Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
CN111094313B (zh) 盐酸伊达比星一水合物的晶型
JP2001506281A (ja) エリスロマイシンａオキシム溶媒和物
CN116496247A (zh) 6-(1-丙烯酰基哌啶-4-基)-2-(4-苯氧基苯基)尼克酰胺的晶型
SK279571B6 (sk) Spôsob čistenia oxytetracyklínu a medziprodukt toh
JP2001507011A (ja) 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用
GB2171408A (en) Mitosane derivative dose preparation
JP2003534231A (ja) 新規の６−デオキシエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用
JPS63233985A (ja) 新規化合物、その製法及びそれを含む医薬組成物